发明名称 Sustained release preparation of pro-insulin C-peptide
摘要 The present invention provides a pharmaceutical composition for the sustained release of C-peptide. The composition is in the form of a gel containing C-peptide. The gel formation is achieved by the adjustment of pH of the composition and/or by addition of divalent metal ions. The composition does not include any other gel-forming agents. Methods for producing the composition, medical uses of the composition and products containing two or more gel compositions as a combined preparation are also encompassed.
申请公布号 US8927489(B2) 申请公布日期 2015.01.06
申请号 US200611916116 申请日期 2006.06.02
申请人 Cebix Incorporated 发明人 Wahren John;Carlsson Anders
分类号 A61K38/28;A61K38/00;A61K38/16;A61K38/10;A61K38/08;A61K38/06;A61K38/04;A61K9/00;A61K47/02 主分类号 A61K38/28
代理机构 Morrison & Foerster LLP 代理人 Morrison & Foerster LLP
主权项 1. A pharmaceutical composition for the sustained release of C-peptide said composition being in the form of a gel comprising colloidal C-peptide, wherein said C-peptide is full length as disclosed in SEQ. ID. Nos. 1-24, or a fragment of each one thereof comprising residues 15-31 when at least 31 residues are present, or as disclosed in SEQ. ID. Nos. 25-31, wherein gel formation is induced by the adjustment of pH of said composition and/or by addition of divalent metal ions, and wherein said composition does not include any gel-forming agents, other than metal ions, if present.
地址 San Diego CA US